ManaMed® Introduces Revolutionary PlasmaFlow® X System for Recovery

ManaMed's Latest Innovation: PlasmaFlow® X

ManaMed has made a significant leap in recovery technology with the introduction of PlasmaFlow® X, a groundbreaking sequential compression system. This innovative device has recently received FDA 510(k) clearance, marking a new chapter in ManaMed's mission to provide effective, patient-centered healthcare solutions.

Transformative Features of PlasmaFlow® X

The PlasmaFlow® X is notably over 30% smaller than its predecessor and boasts double the battery life. This compact design not only conserves space in surgical centers, but it also contributes to a reduction in packaging waste, aligning with modern environmental considerations. The device utilizes USB-C charging, making it convenient and efficient for users needing quick recharges.

Integrated Technology for Enhanced Experience

Equipped with a comprehensive LCD interface, users can now easily monitor critical aspects such as battery life, pressure settings, and patient adherence. This advancement simplifies the user experience, making it both intuitive and informative for both patients and healthcare providers.

PlasmaFlow® X: Designed for Comfort and Effectiveness

Beyond just functionality, the PlasmaFlow® X is engineered for maximum comfort. The low-profile design ensures that patients can wear it without feeling encumbered, enabling mobility even during therapy sessions. As production in this field often raises comfort as a primary concern, the innovative sleeve is designed to meet the practical needs of patients.

A Leap in Sequential Compression Technology

Trevor Theriot, President + CEO of ManaMed, stated, "PlasmaFlow X represents a generational evolution in the sequential compression market. We have completely reimagined its design and user interface to better serve patients and healthcare professionals.” This dedication to innovation highlights ManaMed's commitment to improving recovery outcomes through advanced technology.

Importance of Regulatory Compliance

Recognized as a Class II device approved via the 510(k) process, PlasmaFlow X excels in preventing deep vein thrombosis (DVT). By providing therapeutic pressure to patients who may be immobile for extended periods, it effectively aids in reducing post-operative discomfort and enhances blood circulation. With preset compression settings, the device offers consistency and reliability in various settings, from clinical environments to home use.

Availability and Ordering Information

The PlasmaFlow X device is now available in the U.S. market, providing healthcare facilities and patients access to its advanced features. It can be ordered directly from ManaMed or through authorized distributors. For specifications or purchasing information, visit ManaMed's official website.

About ManaMed and Its Commitment

ManaMed is dedicated to creating innovative orthopedic solutions that help individuals maintain their active lifestyles following injuries or surgeries. The company's extensive product range includes vascular and electrotherapy devices designed to enhance recovery processes. Collaborating with healthcare practitioners across the United States, ManaMed aims to ensure patients receive the best possible care tailored to their needs.

Frequently Asked Questions

What is PlasmaFlow® X?

PlasmaFlow® X is a next-generation sequential compression system created by ManaMed, designed to help prevent DVT and enhance recovery.

What are the key features of the PlasmaFlow® X?

The device is 30% smaller, has double the battery life, features USB-C charging, and provides an intuitive LCD interface for easy monitoring.

How does PlasmaFlow® X improve patient recovery?

It helps reduce post-operative pain and swelling and enhances blood circulation, making it beneficial for patients staying immobile for long periods.

Is PlasmaFlow® X currently available for purchase?

Yes, PlasmaFlow® X has received FDA clearance and is now available through ManaMed and its authorized distributors.

How does ManaMed support active recovery?

ManaMed designs products to facilitate recovery, partnering with healthcare professionals to offer orthopedic solutions that cater to varied patient needs.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.